Jenni Ferris Braught

Dynamic and results-driven sales professional with extensive experience in promoting and selling MassARRAY mass spectrometers and customizable oncology panels across The Americas. Demonstrated expertise in strategic leadership, market analysis, and client relationship management, leading to consistent sales growth. Proven ability to collaborate effectively with Senior Leadership, Marketing, and Regional Account Executives to develop and implement successful strategies for penetrating the oncology diagnostic market in the U.S. and Canada. Skilled in contract negotiations and fostering strong relationships with hospitals, academic institutions, large reference laboratories, and independent labs. Adept at working with GPO's, CRO's, and IDN networks, providing expert guidance on integrating advanced diagnostic tools into budgets and laboratory workflows.

Diversified Commercial Sales Specialist with a strong background in promoting advanced WES/WTS assays for solid tumor DNA and RNA analysis. Successfully covered a large multi-region territory, acquiring valuable insights and expanding professional networks. Proven track record of enrolling a hospital and GPO in Sema4-powered studies, gaining hands-on experience with IRBs and CROs. Demonstrated expertise in somatic assays, liquid biopsy, and frequent collaboration with R&D teams. Adept at strategic planning with senior leadership and medical affairs to drive innovative solutions and optimize outcomes in oncology diagnostics.

Accomplished professional with extensive experience in promoting a portfolio of CGP products and implementing workflows to integrate precision medicine into clinical practice. Skilled in identifying growth opportunities through strategic analysis and developing targeted sales strategies as part of multiple 'Insights' teams. Successfully launched two FDA-approved genetic panels and consistently delivered strong performance, finishing 13th out of 60 in FY2020. Adept at creating competitive battle cards and asking impactful questions to drive success in highly competitive markets.

Specialized in promoting diagnostic cancer genetic testing across diverse medical specialties, including Medical Oncology, Radiation Oncology, Surgery, Genetic Counseling, Gynecological Oncology, Gastroenterology, and Urology. Leveraged established relationships to achieve immediate market penetration, driving significant growth in competitive markets. Skilled in strategizing and executing business plans to capture new business from competitors while deepening engagement within existing accounts. Proven ability to deliver impactful solutions and exceed sales targets in the oncology diagnostics space.

Expertise in promoting patient identification for mCRPC candidates across Medical Oncology, Radiation Oncology, Urology, and Nuclear Medicine for Xofigo (radium 223 dichloride). Achieved top-tier results, maxing out commission in 2017 for new patient starts and total injection volume. Consistently delivered outstanding performance, ranking 21st out of 72 representatives at the time of departure, demonstrating a strong commitment to patient care and business growth.

Selling diagnostic genetic tests and devices for hereditary cancer syndromes to a diverse range of specialists, including Medical, Radiation, Surgical, and Gynecologic Oncologists, Pathologists, and Surgeons. Demonstrated exceptional sales performance, achieving top rankings such as 7th out of 120 in Q3 2016 and 1st out of 120 for CRC SPIFF in 2015. Recognized for leadership abilities and promoted to the New Hire Mentor Program in 2014, showcasing a commitment to excellence and mentorship in the field of oncology diagnostics.

• 16 direct reports

• 3 direct reports

• 3 direct reports